Psychiatr. pro Praxi, 2007; 8(5): 229-231

Jak správně zvolit Antidepresivum

prof. MUDr. Eva Češková CSc
Psychiatrická klinika LF MU a FN Brno

Při volbě antidepresiva jsou rozhodující naše znalosti o léčbě – antidepresivech (AD) a informace o nemocném. Pro zjednodušení lze faktory, ovlivňující naši volbu, rozdělit:

1. na faktory související s léčbou, kdy bereme v úvahu vše, co o jednotlivých antidepresivech víme

2. faktory související s nemocným.

Published: November 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Češková E. Jak správně zvolit Antidepresivum. Psychiatr. praxi. 2007;8(5):229-231.
Download citation

References

  1. Bairy KL, Madhyastha S, Ashok KP et al. Developmental and behavioral consequences of prenatal fluoxetine. Pharmacology 2006; 79: 1-11. Go to original source... Go to PubMed...
  2. Baldwin DS, Montgomery SA, Nil R, Lader M. Discontinuation symptoms in depression and anxiety disorder. Int J Neuropsychopharmacol 2007; 10: 73-84. Go to original source... Go to PubMed...
  3. Bergman LF, Blumenthal J, Burg M et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarcion: the Enhancing recovery in coronary heart disease patientes (ENRICHED) Randomized trial. JAMA 2003; 289: 3106-3116. Go to original source... Go to PubMed...
  4. Češková E. Jak správně zvolit antidepresivum. Čes a slov Psychiat 2003; 99: 267-272.
  5. Češková E. Volba antidepresiva. Remedia 2003; 13: 426-436.
  6. Češková E. Možnosti farmakoterapie deprese. Psychiatr. pro Praxi 2005; 6: 233-236.
  7. Češková E, Pálenský V, Skotáková S. Současné možnosti farmakoterapie deprese. Čes a slov Psychiat 2004; 100: 148-152.
  8. Cohen LS, Monace RM, Bailey JW et al. Relapse of depression during pregnancy following antidepressant discontinuation: a preliminar prospective study. Arch Womens Mental Health 2004; 7: 217-221. Go to original source... Go to PubMed...
  9. De Leon J, Armstrong SC, Cozza KL. Clinical guidelines for psychiatrists for the use of pharmacogenetic treating for CYP450 2D6 and CYP450 2C19. Psychosomatice, 2006; 47: 75-85. Go to original source... Go to PubMed...
  10. Einarson A. The safety of psychotropic drug use during pregnancy: a review. Med Gen Med 2005; 7: 3.
  11. Fava M. Weight gain and antidepressants. J Clin Psychiatry 2000; 61 (Suppl 11): 37-41. Go to original source...
  12. Glassman AH, O´Conner CM, Califf RM et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288: 701-709. Go to original source... Go to PubMed...
  13. Hirschfeld RMA. Long-term side effects of SSRIs: sexual dysfunction and weight gain. J Clin Psychiatry 2003; 64 (suppl 18): 20-24.
  14. Lin EH, Von Korff M, Lin E et al. The role of the primary care physician in patients adherence to antidepressant therapy. Med Care 1995; 33: 67-74. Go to original source... Go to PubMed...
  15. McIntyre RS, Soczynska J, Konarski JZ et al. The effect of antidepressants on glukose homeostasis and insulin sensitivity: synthesis and mechanisms. Exper Opin Drug Saf 2006; 5: 157-168. Go to original source... Go to PubMed...
  16. Merino MJ, Gonzalez P, Muňiz J, Bobes J. Sexual dysfunction in depressed patients undergoing treatment with antidepressants. Int J Psychiatr Clin Practice 2000; 4: 311-317. Go to original source... Go to PubMed...
  17. Mort JR, Aparasu RR, Baer RK. Interaction between selective serotonin reuptake inhibitors and nonsteroidal antiinflammatory drugs: review of the literature. Pharmacotherapy 2006; 25: 1307-1313. Go to original source... Go to PubMed...
  18. Pidrman V. Psychofarmaka v interních a některých dalších oborech medicíny. In: Bouček J, Pidrman V, eds. Psychofarmaka v medicíně. Praha, Grada 2005, 139-261.
  19. Sanz EJ, De-las-Cuevas C, Kiuru A. et al. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005; 365: 482-487. Go to original source...
  20. Thase M, Entsuah R, Cantillon M, Kornstein SG. Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions. J Womens Health 2005; 14: 609-616. Go to original source... Go to PubMed...
  21. Žourková A, Hadašová E. Paroxetine-induced conversion of cytochtrome P450 2D6 phenotype and occurence of adverse effects. Gen Physiol Biophys 2003; 22: 103-113. Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.